INTERNATIONAL CONFERENCE
Dehli, India, 2025
https://eijmr.org/conferences/
INNOVATIONS IN SCIENCE AND EDUCATION SYSTEM
333
VIRAL VS. BACTERIAL PNEUMONIA IN CHILDREN: PATHOPHYSIOLOGICAL
INSIGHTS AND DIAGNOSTIC DILEMMAS
Ergashzoda Khusniya Sharafidin Kizi
Central Asian Medical University
E-mail: ergashzodaxusniya@gmail.com
https://orcid.org/0009-0001-6423-3642
Eminov Ravshanjon Ikromjon ugli
Department of Faculty and Hospital Surgery, FMIOPH, Fergana, Uzbekistan
Abstract:
Pneumonia remains a leading cause of morbidity and mortality in children under five,
especially in low-resource settings such as Uzbekistan. Distinguishing between viral and bacterial
pneumonia is critical for appropriate treatment but remains diagnostically challenging. While viral
pneumonia commonly presents with diffuse infiltrates and systemic symptoms like wheezing, bacterial
pneumonia often has focal consolidation and higher inflammatory markers. However, clinical,
radiological, and biomarker overlap complicates this differentiation. Improved diagnostic tools,
clinician training, and vaccination coverage are essential to enhance pediatric pneumonia management
and reduce unnecessary antibiotic use.
Keywords:
pneumonia, children, diagnosis, virus, bacteria
Introduction
Acute pneumonia is a major infectious disease affecting children worldwide, especially those under
five years of age. Globally, pneumonia accounts for about 14% of all deaths in children under five[1].
In Uzbekistan – a country that has dramatically reduced under-five mortality to ~13.3 per 1,000 live
births – pneumonia remains a leading cause of childhood hospitalization. Pneumonia can be caused by
a wide array of pathogens, most commonly respiratory viruses or bacteria[2]. Importantly, the
aetiological profile of pediatric pneumonia has been altered by widespread vaccination: immunization
against pneumococcus and Hib (introduced in Uzbekistan in 2015 and ~2009, respectively[3]) has
reduced the incidence of bacterial pneumonia. As a result, respiratory viruses (e.g. RSV, influenza,
parainfluenza, adenovirus, rhinovirus) now predominate in many pediatric pneumonia cases[4].
Distinguishing viral from bacterial pneumonia is crucial because it guides treatment –
antibiotics are indicated for bacteria but not viruses – yet this differentiation is notoriously difficult in
clinical practice[5]. The World Health Organization emphasizes that timely antibiotic treatment of
pneumonia can save lives, yet globally only about one-third of children with pneumonia receive
antibiotics[6]. In resource-limited settings such as Uzbekistan, diagnostic facilities are often scarce,
leading to reliance on clinical algorithms. For example, WHO’s Integrated Management of Childhood
Illness (IMCI) classifies any child with cough and fast breathing (or chest indrawing) as pneumonia
INTERNATIONAL CONFERENCE
Dehli, India, 2025
https://eijmr.org/conferences/
INNOVATIONS IN SCIENCE AND EDUCATION SYSTEM
334
requiring antibiotics[7]. This broad approach inevitably results in treating many viral cases with
antibiotics, contributing to overuse and resistance.
This review explores the pathophysiology, clinical presentation, and diagnosis of viral versus bacterial
pneumonia in children, with an emphasis on the practical challenges in Uzbekistan and Central Asia.
We examine the immune and inflammatory mechanisms underlying each type of infection, compare
the distinguishing (and overlapping) clinical features, and critically evaluate diagnostic tools (imaging,
microbiology, biomarkers) for etiology. Our goal is to synthesize current evidence (2015–2025) from
peer-reviewed sources and health authorities to provide an in-depth, evidence-based comparison of
viral and bacterial pneumonia in pediatric populations, and to highlight strategies to improve diagnosis
and management in the region.
Pathophysiology
Both viral and bacterial pneumonias begin with pathogen entry into the lower respiratory tract, but the
subsequent immune responses and tissue effects diverge. The respiratory epithelium and mucociliary
clearance normally serve as primary barriers; viruses and bacteria that evade these defenses trigger
innate immune activation. Viral pneumonia pathogens (e.g. RSV, influenza, adenovirus) infect
respiratory epithelial cells and replicate intracellularly. Infected cells release type I interferons and
other cytokines that orchestrate an antiviral response. Natural killer cells and cytotoxic T lymphocytes
play key roles in containing intracellular viruses, while infected cell death (via necrosis or apoptosis)
can damage the airway lining. The inflammation is often interstitial (affecting septae and peribronchial
tissue) and involves a mononuclear infiltrate (macrophages and lymphocytes)[8]. Notably, severe viral
infections (such as RSV bronchiolitis) can also induce intense neutrophilic inflammation: for example,
infants with severe RSV pneumonia may have neutrophils comprising >90% of bronchial lavage
cells[9]. Cytokine profiles in viral pneumonia often feature elevated interferon-α/β and interleukin-10
(anti-inflammatory) in addition to IL-6 and IL-8; however, the exact patterns can vary among viruses.
Table
. Comparision of VP vs BP
Feature
Viral Pneumonia
Bacterial Pneumonia
Common
pathogens
RSV, influenza, rhinovirus, parainfluenza,
adenovirus, etc.
Streptococcus pneumoniae
,
H.
influenzae
type b,
Staphylococcus
aureus
,
Mycoplasma pneumoniae
,
etc.[11]
Initial
infection
site
Bronchiolar and interstitial (alveolar
walls); often bilateral involvement[12]
Alveolar spaces and bronchi; often
focal
lobar
or
segmental
consolidation
Immune response
Predominantly
interferon-mediated,
lymphocytic/mononuclear infiltrate; can
include neutrophils in severe cases (e.g.
RSV)[8]
Neutrophil-dominated
inflammation
with
pro-
inflammatory cytokines (IL-1, IL-
6, IL-8, TNF-α)
Inflammatory
exudate
Serous or mucopurulent; less voluminous
exudate
Purulent exudate filling alveoli,
may form lobar consolidation
Fever pattern
Often low-grade or fluctuating; can be
prolonged (e.g. influenza causes high High, continuous fever is common
INTERNATIONAL CONFERENCE
Dehli, India, 2025
https://eijmr.org/conferences/
INNOVATIONS IN SCIENCE AND EDUCATION SYSTEM
335
fever)
Onset
and
prodrome
Often gradual, preceded by URTI
symptoms (runny nose, sore throat)
Often abrupt onset, sometimes
after viral URTI
Cough
characteristics
Typically dry or hacking; can progress to
productive if secondary infection
Usually productive or severe cough
Chest findings
Bilateral diffuse crackles; wheezing
common (esp. RSV, influenza)[4]
Focal crackles, bronchial breath
sounds, localized dullness to
percussion if lobar
Radiographic
pattern
Diffuse
or
interstitial
infiltrates;
peribronchial cuffing (e.g. “cloud-like”
opacities)[7]
Lobar or segmental consolidation
(dense opacity); air bronchograms
WBC/biomarkers
WBC normal or low; lymphocyte
predominance; moderate CRP, PCT rise if
severe
WBC elevated with neutrophilia;
often higher CRP and PCT (though
overlap)
Typical course
Usually self-limited in healthy children;
recovery in ~1–2 weeks; complications
less common
Can be severe or fulminant;
complications (pleural effusion,
empyema) more common
Treatment
implications
Supportive care; antiviral therapy for
specific viruses (e.g. oseltamivir for
influenza); antibiotics not routinely needed
Prompt antibiotics (e.g. amoxicillin
or penicillin derivatives) are
indicated;
hospitalization and IV antibiotics
for severe cases
Clinical Features
The clinical presentation of pneumonia in children often overlaps between viral and bacterial causes.
Common symptoms in both include cough, tachypnea (fast breathing), fever, and respiratory
distress. Viral pneumonia frequently begins with upper respiratory symptoms: rhinorrhea, nasal
congestion, and cough, sometimes with wheezing or stridor. Fever may be low-grade or variable, and
the child may have scattered crackles or wheezes bilaterally on auscultation[13]. Viral infections often
involve both lungs diffusely; for example, clinicians may find decreased air entry or crackles in
multiple lung fields. In contrast, bacterial pneumonia in a child often presents more acutely with high
continuous fever, marked toxicity, and often a history of sudden onset. Physical exam may reveal focal
findings: localized bronchial breath sounds, dullness to percussion, or pleural rub if effusion is present.
One lung lobe or segment is typically more affected, consistent with lobar consolidation. Cough is
often productive (though children may swallow sputum), and the illness can progress to severe
respiratory distress if not treated.
Despite these tendencies, many findings are nonspecific. For instance, wheezing is more often
associated with viral etiologies (e.g. RSV) but can occur in bacterial superinfection or asthma overlap.
Likewise, both types can cause hypoxia, dehydration, or failure to thrive in severe cases. WHO notes
that “presenting features of viral and bacterial pneumonia are similar” in young children, with subtle
clues only (e.g. wheeze more common in viral). A systematic review affirms that no single clinical
finding reliably distinguishes the two, so a combination of signs is used.
INTERNATIONAL CONFERENCE
Dehli, India, 2025
https://eijmr.org/conferences/
INNOVATIONS IN SCIENCE AND EDUCATION SYSTEM
336
Prognosis also differs: most viral pneumonias in children are self-limited, and long-term sequelae are
rare. By contrast, certain bacterial pneumonias can be fulminant: for instance,
Staphylococcus
aureus
or varicella-associated pneumonia can have high mortality in children. Influenza pneumonia in
particular can be severe, as noted earlier. Table 1 above summarizes the contrasting clinical and
laboratory features of viral versus bacterial pediatric pneumonia.
Diagnostic Tools
Diagnosing the cause of pneumonia requires combining clinical, radiographic, microbiologic, and
laboratory information. No single test is definitive, and resource limitations in Uzbekistan and similar
regions complicate matters. Common diagnostic modalities include chest imaging, microbiological
cultures/PCR, and biomarkers, each with strengths and weaknesses.
Chest Radiography is widely used to confirm pneumonia but cannot reliably distinguish viral
from bacterial cause. A posteroanterior (PA) chest X-ray remains the reference standard for diagnosing
pneumonia. In viral pneumonia, radiographs often show bilateral diffuse or interstitial infiltrates
(occasionally described as “ground-glass” opacities), reflecting widespread inflammation. In bacterial
pneumonia, one typically sees dense opacification in one lobe or segment, often with air bronchograms
(see Figure 1). However, overlap is common: partial lobar consolidation can occur with viruses, and
multifocal infiltrates with bacteria. Radiography also requires equipment and radiation safety, which
may be limited outside major hospitals.
Figure: Chest radiograph of a child with viral pneumonia (CMV infection), demonstrating bilateral
diffuse interstitial infiltrates (indicated by hazy opacification in both lungs). In contrast to the focal
lobar consolidation expected in bacterial pneumonia, the diffuse pattern suggests a viral etiology.
Such imaging helps support a clinical suspicion but is not definitively diagnostic.
Lung Ultrasound (LUS) has emerged as a valuable alternative, especially in children where
radiation avoidance is preferred. Ultrasound can detect consolidations, interstitial syndrome, and
pleural effusions. Several studies report high sensitivity and specificity for pneumonia detection by
LUS, and it may reveal differences: bacterial pneumonia often produces larger, subpleural
consolidations with “hepatized” lung and dynamic air bronchograms, whereas viral pneumonia tends
to yield smaller subpleural consolidations and diffuse B-lines (vertical artifacts). In one observational
study, children with bacterial pneumonia had significantly higher LUS scores than those with viral
infection[14]. A meta-analysis concludes LUS is a viable alternative to X-ray in pediatric pneumonia.
However, LUS requires training, and its availability in rural clinics is limited.
Microbiological Tests: Identifying the causative pathogen definitively is ideal but often
challenging. Blood cultures in pediatric pneumonia have low yield (often <10%) and are slow[15].
Sputum culture is seldom possible in young children. Nasopharyngeal (NP) swabs or aspirates allow
PCR or antigen tests for viruses: these are highly sensitive, and multiplex PCR panels can detect RSV,
influenza, rhinovirus, etc. However, detection of a virus does not prove it is the pneumonia cause,
since asymptomatic viral carriage is common. For example, one study found similar rates of viral
detection (~77–78%) in children with severe pneumonia and in controls without pneumonia. PCR
panels for atypical bacteria (e.g.
Mycoplasma pneumoniae
,
Chlamydia pneumoniae
) and respiratory
cultures (for tuberculosis, etc.) can be done but are not universally available. In Uzbekistan, routine
INTERNATIONAL CONFERENCE
Dehli, India, 2025
https://eijmr.org/conferences/
INNOVATIONS IN SCIENCE AND EDUCATION SYSTEM
337
viral PCR testing is likely limited to reference labs, so most clinicians rely on rapid antigen tests (for
influenza/RSV if accessible) or empirical judgment.
Biomarkers: Blood tests such as C-reactive protein (CRP) and procalcitonin (PCT) are
frequently measured. As noted, CRP tends to be higher in bacterial pneumonia, though with
considerable overlap. PCT has been studied as a decision aid: a meta-analysis found PCT (cutoff ~0.5
ng/mL) had sensitivity ~68% and specificity ~60–72% for bacterial pneumonia in children. Neither
marker alone is definitive. The 2021 Pediatric Infectious Diseases Society meta-analysis concluded
that CRP and PCT performed modestly (AUROC ~0.70 each) and that novel biomarkers (e.g. cytokine
profiles) might eventually help. In practice, elevated CRP/PCT may support antibiotic use, but normal
values cannot rule out bacterial infection in a seriously ill child. White blood cell count and
erythrocyte sedimentation rate perform even worse and are not reliable discriminators. Other tests
like
urine pneumococcal antigen
have poor specificity in children (due to nasopharyngeal carriage)
and are not recommended.
In resource-limited settings like rural Uzbekistan, many of these tools are unavailable. Often the initial
assessment is based on history and physical exam alone (e.g. IMCI protocol). Chest radiography may
not exist at district clinics, and lab turnaround times are long. This diagnostic uncertainty drives
empirical treatment. As one U.S. pediatric text warns, “Diagnosis [of pneumonia] still remains
challenging,” underscoring the difficulty of distinguishing viral from bacterial pneumonia at the
bedside.
Challenges
Distinguishing viral versus bacterial pneumonia in children is fraught with challenges, particularly in
low-resource settings. Major issues include:
Symptom Overlap and Diagnostic Uncertainty: As noted, clinical features are insufficiently
specific[17]. In practice, a child with cough and fast breathing is treated as pneumonia per WHO
guidelines, regardless of presumed cause. This approach errs on the side of treating possible bacterial
infection, but leads to antibiotic use in many viral cases.
Resource Limitations: In Uzbekistan and similar contexts, access to imaging and laboratory
tests is uneven. Only large hospitals in Tashkent or regional centers may have X-ray and lab facilities;
rural clinics rely on clinical diagnosis. PCR and multiplex diagnostics are largely confined to research
settings. Pulse oximetry and oxygen may not be available in small clinics. Even when tests exist,
turnaround time may be too slow to guide immediate therapy.
Laboratory and Radiology Variability: Even when available, test interpretation is not
straightforward. Radiographs require experience: subtle interstitial infiltrates in viral pneumonia can be
missed or misread. Inter-observer variation is high in pediatric chest X-rays. Lab tests have inherent
variability: CRP measured by different assays or a WBC count can be confounded by malnutrition,
malaria, or other local factors.
Overall, these challenges underline why clinicians in resource-poor settings rely on broad empiricism.
A combination of rapid clinical deterioration (suggesting bacterial sepsis) and laboratory support (e.g.
very high CRP) may guide more aggressive treatment, whereas milder, gradual cases may be observed
or managed with symptomatic care. Efforts to develop rapid point-of-care diagnostics (such as CRP
tests, viral rapid tests, or LUS) are ongoing and could transform care in settings like Uzbekistan.
INTERNATIONAL CONFERENCE
Dehli, India, 2025
https://eijmr.org/conferences/
INNOVATIONS IN SCIENCE AND EDUCATION SYSTEM
338
Treatment
Management of pediatric pneumonia differs fundamentally between viral and bacterial etiologies.
However, in practice, initial treatment often overlaps due to diagnostic uncertainty.
For bacterial pneumonia, prompt antibiotic therapy is indicated. The World Health Organization
recommends oral amoxicillin dispersible tablets as first-line treatment for non-severe pneumonia in
children. In hospitalized cases or very severe pneumonia, parenteral antibiotics are used:
benzylpenicillin or ampicillin (typically at 100,000–200,000 units/kg/day) with gentamicin is common
as empiric therapy to cover
S. pneumoniae
,
H. influenzae
, and others. If
Staphylococcus aureus
or
other resistant organisms are suspected, vancomycin or clindamycin may be added. Importantly, local
treatment protocols (such as Uzbekistan’s pediatric guidelines) generally follow WHO/IDSA
recommendations. In Uzbekistan, standard practice at the community level is to administer amoxicillin
for presumed pneumonia, reflecting these guidelines.
By contrast, viral pneumonia treatment is primarily supportive. Oxygen therapy is critical for any child
with hypoxemia. Ensuring adequate hydration and nutrition is also essential. Fever can be managed
with antipyretics (acetaminophen/ibuprofen). There are a few specific antiviral treatments: for example,
oseltamivir (an oral neuraminidase inhibitor) is indicated for influenza pneumonia if given early,
especially in high-risk children. Ribavirin has been used (inhaled or IV) for severe RSV infection, but
its use is limited and generally reserved for life-threatening cases due to toxicity and mixed evidence.
Otherwise, no specific antivirals exist for most pediatric respiratory viruses (e.g. adenovirus,
rhinovirus), so care is supportive. Corticosteroids are not generally indicated except in specific
situations (e.g.
Pneumocystis jiroveci
pneumonia in an HIV-infected child, or airway hyperreactivity).
Conclusion
In summary, viral and bacterial pneumonia in children differ in their etiologies, immune responses,
clinical courses, and management, but they can present with overlapping symptoms that make rapid
differentiation difficult. Viral agents (RSV, influenza, rhinovirus, etc.) now predominate in pediatric
pneumonia in Uzbekistan and Central Asia, especially after widespread vaccination against Hib and
pneumococcus. Viral pneumonias tend to produce diffuse bilateral lung involvement, wheezing, and a
self-limited course, whereas bacterial pneumonias often cause focal consolidation, high fever, and can
be life-threatening. Yet features alone are unreliable, and even laboratory tests (CRP, PCT) and
imaging have only moderate accuracy. As a result, clinical practice in resource-limited settings
frequently errs on the side of giving antibiotics to any child with suspected pneumonia.
References
:
1.
Adhamjon
ogh,
A.
A.
Z.,
&
Mominjonovna,
M.
B.
(2025,
May).
CLINICAL
PHARMACOLOGY
OF
ANTI-INFLAMMATORY
DRUGS.
In
CONFERENCE
OF
MODERN
SCIENCE
&
PEDAGOGY
(Vol.
1,
No.
2,
pp.
88-91).
2.
Boboxonova,
M.
(2025).
COMBATING
EARLY
MENOPAUSE:
MODERN
MEDICAL
APPROACHES
AND
NATURAL
TREATMENT
METHODS.International
Journal
of
Artificial
Intelligence,
1(4),
56-59.
INTERNATIONAL CONFERENCE
Dehli, India, 2025
https://eijmr.org/conferences/
INNOVATIONS IN SCIENCE AND EDUCATION SYSTEM
339
3.
Boretskaya,
A.
S.
(2025).
VIRAL
VECTORS.
STUDY
AND
RESEARCH
OF
DNA
AND
RNA
CONTAINING
VIRUSES.Western
European
Journal
of
Medicine
and
Medical
Science,
3(05),
38-41.
4.
Boretskaya,
A.,
Farid,
M.
E.,
Egorova,
S.,
&
Lamberov,
A.
(2022).
Transformation
of
amorphous
aluminum
oxide
in
the
catalytic
dehydration
reaction
of
aromatic
alcohol.
5.
Ganiyeva
M.
R.
CLINICAL
AND
MORPHOFUNCTIONAL
CHANGES
IN
THE
RETINA
IN
HIGH
MYOPIA
IN
COMBINATION
WITH
AGE-RELATED
MACULAR
DEGENERATION
OF
DIFFERENT
STAGES
//International
Conference
on
Modern
Science
and
Scientific
Studies.
–
2024.
–
P.
141-142.
6.
Ikromova,
N.
(2024).
CHEMICAL
PROPERTIES
AND
PRACTICAL
IMPORTANCE
OF
NATURAL
CYANOGLYCOSIDE-AMYGDALIN.
Universal
International
Scientific
Journal,
1(6),
26-29.
7.
Ikromova,
N.
(2024,
October).
PROSPECTS
OF
SYNTHESIS
OF
AMIGDALIN
DERIVATIVES.
In
CONFERENCE
ON
THE
ROLE
AND
IMPORTANCE
OF
SCIENCE
IN
THE
MODERN
WORLD
(Vol.
1,
No.
8,
pp.
164-166).
8.
Mo'Minjonovna,
B.
M.,
&
O'G'Lee,
M.
A.
R.
(2024).
STUDY
AND
ANALYSIS
OF
THE
PHARMACOLOGICAL
PROPERTIES
OF
MEDICINAL
PLANTS
WHICH
ARE
CARDIAC
GLYCOSIDES
USED
IN
CLINICAL
PRACTICE.Eurasian
Journal
of
Medical
and
Natural
Sciences,
4(1-1),
80-83.
9.
Rakiboyevna,
G.
M.,
&
Abdulhay,
M.
(2025).
PREVENTION
OF
COMPLICATIONS
OF
CARDIOVASCULAR
DISEASES
BY
ORGANIZING
MORPHOLOGICAL
AND
CLINICAL
INDICATORS
OF
ARCUS
SENILIS.Modern
education
and
development,
26(4),
201-204.
10.
Rakhibovna,
G.
M.,
&
Abdulhay,
M.
(2025,
May).
MORPHOLOGICAL
AND
CLINICAL
INDICATIONS
OF
COMPLICATIONS
OF
CARDIOVASCULAR
DISEASE
ARCUS
SENILIS.In
International
Conference
on
Multidisciplinary
Sciences
and
Educational
Practices
(pp.
182-184).
11.
Бобохонова, М. М., & Дехконбоева, К. А. (2021). НАЦИОНАЛЬНАЯ МОДЕЛЬ ОХРАНЫ
ЗДОРОВЬЯ МАТЕРИ И РЕБЕНКА В УЗБЕКИСТАНЕ:" ЗДОРОВАЯ МАТЬ-ЗДОРОВЫЙ
РЕБЕНОК". Экономика и социум, (10 (89)), 540-543.
12.
Борецкая, А. С. (2022). СОСТОЯНИЕ ОБРАЗОВАНИЯ И ПЕДАГОГИЧЕСКОЙ МЫСЛИ
В ЭПОХУ БЕРУНИ. Academic research in educational sciences, (3), 125-127.
13.
Борецкая, А. С., Расулов, Ф. Х., Рузалиев, К. Н., & Хасанов, Н. Ф. У. (2024).
ИММУНОГЕНЕЗ И МИКРОФЛОРА КИШЕЧНИКА ПРИ ПАТОЛОГИИ СМЕШАННОЙ
ЭТИОЛОГИИ И ПУТИ ИХ КОРРЕКЦИИ. Science and innovation, 3(Special Issue 45), 276-281.
14.
Икромова, Н. М. (2024). Научно-Теоретические Основы Социальной Адаптации
Старшего Дошкольника На Основе Речевого Развития. Miasto Przyszłości, 54, 385-387.
15.
Икромова, Н., & Эминов, Р. (2025). Влияние эмоционального интеллекта и уровня
тревожности на развитие речи и социальную адаптацию детей дошкольного возраста. in Library,
1(2), 15-19.
INTERNATIONAL CONFERENCE
Dehli, India, 2025
https://eijmr.org/conferences/
INNOVATIONS IN SCIENCE AND EDUCATION SYSTEM
340
16. Икромова, Н., & Эминов, Р. (2025). Развитие речи и языка у дошкольников: роль
родительского взаимодействия. in Library, 1(2), 28-32.
17. Расулов, Ф. Х., Борецкая, А. С., Маматкулова, М. Т., & Рузибаева, Ё. Р. (2024). INFLUENCE
AND STUDY OF MEDICINAL PLANTS OF UZBEKISTAN ON THE IMMUNE SYSTEM. Web of
Medicine: Journal of Medicine, Practice and Nursing, 2(12), 118-124.
18. Расулов, Ф., Тожалиевна, М., Рузибаева, Ё., & Борецкая, А. (2024). Исследование стабильной
формы коронавируса и ее устойчивости к изменчивости. Профилактическая медицина и
здоровье, 3(3), 20-26.
19. Мухаммадиев, С., Нишонов, Э., & Эминов, Р. (2025). ОБУЧЕНИЕ НА ОСНОВЕ
СИМУЛЯЦИИ ДЛЯ ОРДИНАТОРОВ-ОРТОПЕДОВ: ВЛИЯНИЕ НА ХИРУРГИЧЕСКУЮ
УВЕРЕННОСТЬ И ОВЛАДЕНИЕ НАВЫКАМИ. in Library, 1(2), 485-489.
20. Тешабоев, А. М., Юлчиева, С. Т., Расулов, У. М., Борецкая, А. С., & Расулов, Ф. Х.
ИЗУЧЕНИЕ ИММУНОГЕНЕЗА И ГЕМОПОЭЗА У ЖИВОТНЫХ С ТИ-ПОМ
АЦЕТИЛИРОВАНИЯ И ПУТИ ИХ КОРРЕКЦИИ С ОЧИЩЕННЫМ КОМПЛЕКСОМ
ДЕТОКСИОМЫ.
